Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fredun Pharmaceuticals Ltd has informed BSE regarding the details of Voting results at the Annual General Meeting (AGM) of the Company held on September 27, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report. Outcome of AGM
Fredun Pharmaceuticals Ltd has informed BSE that the 29th Annual General Meeting (AGM) of the Company was held on September 27, 2016. Standalone Financial Results, Limited Review Report for June 30, 2016
Fredun Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 2016 Outcome of Board Meeting
Fredun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2016, Loan from HDFC BankThe chairman placed on the table the proposal received from HDFC Bank for the financial assistance to the company for the Business activities of the company. The matter was discussed by the Board and the same was approved the necessary resolution was passed. Board Meeting Intimation for Results
Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 11, 2016, to consider approve and take on records the unaudited financial results for the Quarter ended June 30, 2016. Fixes Book Closure for AGM
Fredun Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2016 to September 27, 2016 (both days inclusive) for the purpose of 29th Annual General Meeting (AGM) of the Company to be held on September 27, 2016. Shareholding for the Period Ended June 30, 2016
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here Outcome of Board Meeting
Fredun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 08, 2016, has transacted the following :1. The Board discussed the matter of issuing and allotting 8% Redeemable Cumulative Preference Shares to the extent of Rs. 2.50 Crores subject to the Provisions of Section 42, 55,62 of The Companies Act, 2013. The Chairperson informed the Board that the Company can allot the shares to 8... Results as per the Scrutinizer's Report for the EGM held on May 30, 2016
Fredun Pharmaceuticals Ltd has informed BSE regarding Results as per the Scrutinizer's Report for the EGM held on May 30, 2016. Outcome of EGM
Fredun Pharmaceuticals Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on May 30, 2016.